CaliPharms Inc

CaliPharms Inc

KGET - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$474.35K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CaliPharms IncCaliPharms Inc-0.4-73%--
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$474,349.00
Enterprise Value$679,741.00
Earnings per Share$0
Beta5.05
Outstanding Shares3,363,083,955

Return

Return on Equity72.64%ROE
Return on Assets-37207.62%
Return on Invested Capital9.35%

Valuation & Multiples

P/E Ratio-0.4P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue6.04
Enterprise Value to EBIT-0.83
Enterprise Value to Net Income-1
Total Debt to Enterprise0.33
Debt to Equity-0.03Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About CaliPharms Inc

2 employees

CaliPharms Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.